Heterocyclic compounds as nras inhibitors
US-2026070925-A1 · Mar 12, 2026 · US
This page is not indexed by search engines while we improve data quality.
Cross Jason patents
Cross Jason is listed as an inventor on 33 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Cross Jason |
| Total patents | 33 |
| First publication | Nov 30, 2017 |
| Latest publication | Mar 12, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Inhibitors of receptor interacting protein kinase i for the treatment of disease
US-2025214942-A1 · Jul 3, 2025 · US
Inhibitors of receptor interacting protein kinase I for the treatment of disease
US-12286406-B2 · Apr 29, 2025 · US
Inhibitors of receptor interacting protein kinase i for the treatment of disease
US-2024199554-A1 · Jun 20, 2024 · US
Heterocyclic inhibitors of PTPN11
US-11840536-B2 · Dec 12, 2023 · US
Inhibitors of receptor interacting protein kinase I for the treatment of disease
US-11753381-B2 · Sep 12, 2023 · US
Inhibitors of receptor interacting protein kinase I for the treatment of disease
US-11718612-B2 · Aug 8, 2023 · US
Inhibitors of receptor interacting protein kinase I for the treatment of disease
US-11690850-B2 · Jul 4, 2023 · US
Heterocyclic inhibitors of ptpn11
US-2023109858-A1 · Apr 13, 2023 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
US-11560366-B2 · Jan 24, 2023 · US
Recent patents
Latest publications not already listed above.
Heterocyclic inhibitors of PTPN11
US-11466017-B2 · Oct 11, 2022 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease
US-2022267311-A1 · Aug 25, 2022 · US
Heterocyclic inhibitors of tyrosine kinase
US-2022194940-A1 · Jun 23, 2022 · US
Heterocyclic inhibitors of tyrosine kinase
US-11365189-B2 · Jun 21, 2022 · US
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US-11173145-B2 · Nov 16, 2021 · US
Inhibitors of receptor interacting protein kinase i for the treatment of disease
US-2021154204-A1 · May 27, 2021 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease
US-2021115010-A1 · Apr 22, 2021 · US
Inhibitors of receptor interacting protein kinase i for the treatment of disease
US-2021094921-A1 · Apr 1, 2021 · US
Inhibitors of receptor interacting protein kinase i for the treatment of disease
US-2021094951-A1 · Apr 1, 2021 · US
Heterocyclic inhibitors of ptpn11
US-2021017182-A1 · Jan 21, 2021 · US
Heterocyclic inhibitors of PTPN11
US-10851110-B2 · Dec 1, 2020 · US
Heterocyclic inhibitors of tyrosine kinase
US-2020354343-A1 · Nov 12, 2020 · US
Ptpn11 inhibitors
US-2020048249-A1 · Feb 13, 2020 · US
Substituted heterocyclic inhibitors of ptpn11
US-2019389867-A1 · Dec 26, 2019 · US
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US-2019365718-A1 · Dec 5, 2019 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
US-10428057-B2 · Oct 1, 2019 · US
Heterocyclic inhibitors of ptpn11
US-2019270746-A1 · Sep 5, 2019 · US
Heterocyclic inhibitors of PTPN11
US-10280171-B2 · May 7, 2019 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease
US-2019092764-A1 · Mar 28, 2019 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
US-10093664-B2 · Oct 9, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Texas | 33 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 28 |
| C07D487/04 | 21 |
| C07D471/04 | 20 |
| A61K31/4985 | 17 |
| C07D401/14 | 17 |